×
About 7,810 results

ALLMedicine™ Ventricular Fibrillation Center

Research & Reviews  2,501 results

Atrial fibrillation begets ventricular fibrillation when the AV node fails.
https://doi.org/10.1016/j.jelectrocard.2022.11.003
Journal of Electrocardiology; Verheul LM, Groeneveld SA et. al.

Nov 29th, 2022 - Deterioration of atrial fibrillation into ventricular fibrillation has frequently been described in patients with pre-excitation of the ventricles. We report two cases of atrial fibrillation without pre-excitation leading to rapid ventricular tach...

Sex disparities in prehospital advanced cardiac life support in out-of-hospital cardiac...
https://doi.org/10.1016/j.ajem.2022.11.025
The American Journal of Emergency Medicine; Hosomi S, Zha L et. al.

Nov 29th, 2022 - Sex disparities in out-of-hospital cardiac arrest (OHCA) care processes have been reported. This study aimed to investigate the association between sex and prehospital advanced cardiac life support (ACLS) interventions provided by emergency medica...

Acute Lung Injury and Recovery in Patients with Refractory VT/VF Cardiac Arrest Treated...
https://doi.org/10.1016/j.resuscitation.2022.11.017
Resuscitation Gutierrez A, Kalra R et. al.

Nov 29th, 2022 - Describe the lung injury patterns among patients presenting with refractory ventricular tachycardia/ventricular fibrillation out-of-hospital cardiac arrest (VT/VF OHCA) supported with veno-arterial extracorporeal membrane oxygenation (VA-ECMO) fac...

The Utility of Sodium Channel Provocation in Unexplained Cardiac Arrest Survivors and E...
https://doi.org/10.1161/CIRCEP.122.011263
Circulation. Arrhythmia and Electrophysiology; Ensam B, Cheung CC et. al.

Nov 29th, 2022 - The implications of a drug-induced type 1 Brugada ECG pattern following sodium channel blocker provocation (SCBP) are not fully understood. Baseline clinical and ECG data were obtained from consecutive unexplained cardiac arrest survivors undergoi...

Esmolol, vector change, and dose-capped epinephrine for prehospital ventricular fibrill...
https://doi.org/10.1016/j.ajem.2022.11.019
The American Journal of Emergency Medicine; Stupca K, Scaturo N et. al.

Nov 28th, 2022 - Refractory ventricular fibrillation (VF) and pulseless ventricular tachycardia (pVT) cardiac arrest describes a subset of patients who do not respond to standard Advanced Cardiac Life Support (ACLS) interventions and are associated with poor outco...

see more →

Guidelines  5 results

2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Position Statement o...
https://doi.org/10.1016/j.cjca.2020.04.004
The Canadian Journal of Cardiology; Deyell MW, AbdelWahab A et. al.

Jun 17th, 2020 - This Canadian Cardiovascular Society position statement is focused on the management of sustained ventricular tachycardia (VT) and ventricular fibrillation (VF) that occurs in patients with structural heart disease (SHD), including previous myocar...

2018 American Heart Association Focused Update on Advanced Cardiovascular Life Support ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324904
Circulation Panchal AR, Berg KM et. al.

Dec 21st, 2018 - Antiarrhythmic medications are commonly administered during and immediately after a ventricular fibrillation/pulseless ventricular tachycardia cardiac arrest. However, it is unclear whether these medications improve patient outcomes. This 2018 Ame...

European Resuscitation Council Guidelines for Resuscitation: 2018 Update - Antiarrhythm...
https://doi.org/10.1016/j.resuscitation.2018.11.018
Resuscitation Soar J, Perkins GD et. al.

Nov 30th, 2018 - This European Resuscitation Council (ERC) Guidelines for Resuscitation 2018 update is focused on the role of antiarrhythmic drugs during advanced life support for cardiac arrest with shock refractory ventricular fibrillation/pulseless ventricular ...

Practice guideline summary: Reducing brain injury following cardiopulmonary resuscitati...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447399
Neurology Geocadin RG, Wijdicks E et. al.

May 12th, 2017 - To assess the evidence and make evidence-based recommendations for acute interventions to reduce brain injury in adult patients who are comatose after successful cardiopulmonary resuscitation. Published literature from 1966 to August 29, 2016, was...

Guideline for resuscitation in cardiac arrest after cardiac surgery.
https://doi.org/10.1016/j.ejcts.2009.01.033
European Journal of Cardio-thoracic Surgery : Official Jo... Dunning J, Fabbri A et. al.

Mar 20th, 2009 - The Clinical Guidelines Committee of the European Association for Cardio-Thoracic Surgery provides this professional view on resuscitation in cardiac arrest after cardiac surgery. This document was created using a multimodal methodology for eviden...

see more →

Drugs  128 results see all →

Clinicaltrials.gov  179 results

Potassium Chloride in Out-of-hospital Cardiac Arrest Due to Refractory Ventricular Fibrillation
https://clinicaltrials.gov/ct2/show/NCT04316611

Sep 27th, 2022 - Out-of-hospital cardiac arrest (OHCA) has a poor prognosis, with an overall survival rate of about 5% at discharge. Shockable rhythm cardiac arrests (ventricular fibrillation (VF) and pulseless ventricular tachycardia) have a better prognosis. In ...

SI + CC Versus 3:1 C:V Ratio During Neonatal CPR
https://clinicaltrials.gov/ct2/show/NCT02858583

Sep 26th, 2022 - Background The majority of newborn infants successfully make the transition from fetal to neonatal life without any help. However, an estimated 10% of newborns need help to establish effective ventilation, which remains the most critical step of n...

DOuble SEquential External Defibrillation for Refractory VF
https://clinicaltrials.gov/ct2/show/NCT04080986

Sep 22nd, 2022 - Double sequential external defibrillation (DSED) and vector change defibrillation have been proposed as viable options for patients in refractory ventricular fibrillation (VF) during out-of-hospital cardiac arrest. However, currently there is insu...

The Validation and Development of Termination-of-Resuscitation (TOR) Rules in OHCA Patients in Asia Countries
https://clinicaltrials.gov/ct2/show/NCT05545176

Sep 22nd, 2022 - Objectives/Hypotheses Prehospital termination-of-resuscitation (TOR) rules were developed in North American and European sites. Whether they remained valid in different geographic, ethnic, and cultural background areas is still under debate. Diffe...

Early Initiation of Extracorporeal Life Support in Refractory OHCA
https://clinicaltrials.gov/ct2/show/NCT03101787

Aug 12th, 2022 - There are approximately 275,000 cases of out-of-hospital cardiac arrest (OHCA) per year in Europe, of which two-thirds have a primary cardiac origin. However, despite adequate conventional cardiopulmonary resuscitation (CCPR) and attempted defibri...

see more →

News  289 results

In Refractory VF, DSED or VC Strategies Both Beat Standard Defibrillation
https://www.medscape.com/viewarticle/983677

Nov 7th, 2022 - Among patients with refractory ventricular fibrillation (VF), survival to hospital discharge was more frequent with double sequential external defibrillation (DSED) and vector-change (VC) defibrillation than with the standard approach, a cluster-r...

Novel Head-Up CPR Position Raises Odds of Survival of Out-Of-Hospital Heart Attacks
https://www.medscape.com/viewarticle/982409

Oct 13th, 2022 - Individuals who experience out-of-hospital cardiac arrest (OHCA) with nonshockable presentations have a better chance of survival when first responders use a novel CPR approach that includes gradual head-up positioning combined with basic but effe...

Azacitidine/Quizartinib Combo Showcases Early Activity in MDS, MDS/MPN With FLT3 or CBL Mutations
https://www.onclive.com/view/azacitidine-quizartinib-combo-showcases-early-activity-in-mds-mds-mpn-with-flt3-or-cbl-mutations

Sep 6th, 2022 - The combination of azacitidine and quizartinib produced preliminary responses in patients with myelodysplastic syndrome (MDS) and MDS/myeloproliferative neoplasms (MPN) whose tumors harbored FLT3 or CBL mutations, according to data from a phase 1/...

Heed Cardiac Risk of Bruton Tyrosine Kinase Inhibitors for CLL
https://www.medscape.com/viewarticle/977772

Jul 22nd, 2022 - A new, industry-funded consensus statement from an international team of hematologists, oncologists, and cardio-oncologists urges caution regarding the cardiac risks of Bruton tyrosine kinase inhibitors (BTKis) in treating chronic lymphocytic leuk...

Heed cardiac risk of BTKis for CLL
https://www.mdedge.com/hematology-oncology/article/256413/cll/heed-cardiac-risk-btkis-cll
Randy Dotinga

Jul 21st, 2022 - A new, industry-funded consensus statement from an international team of hematologists, oncologists, and cardio-oncologists urges caution regarding the cardiac risks of Bruton tyrosine kinase inhibitors (BTKis) in treating chronic lymphocytic leuk.

see more →

Patient Education  22 results see all →